More Questions We've Answered Related to This Product
We’ve provided several answers to questions related to Ongentys (Opicapone) , see some other helpful Q&A related to this product.
-
Question: What should you do if you have end-stage kidney disease?
Answer: You should avoid treatment with Ongentys if you have end-stage kidney disease. This is important because it reduces the risk of further complicating kidney health and ensures patient safety.
-
Question: What medical conditions should prevent the use of Ongentys?
Answer: You should not take Ongentys if you have had pheochromocytoma, paraganglioma, or other tumors that secrete catecholamines. This precaution helps avoid exacerbating these conditions, ensuring the patient's safety.
-
Question: What are the available dosages for Ongentys?
Answer: Ongentys is available in 25 mg and 50 mg oral capsules. Offering different dosage options allows for personalized treatment plans that can be adjusted based on the patient's specific needs and medical conditions.
